Synthesis and antitumor evaluation of novel tetrahydrobenzo[4′,5′]thieno[3′,2′:5,6]pyrimido[1,2-b]isoquinoline derivatives

Mahmoud, Mahmoud R.; Mohamed Hekal; Ali, Yasmeen M.; Abu El-Azm, Fatma; Ismail, Mahmoud;

Abstract


In the present study, a novel 8,9,10,11-tetrahydro-7H,14H-benzo[4′,5′] thieno[2′,3′:4,5]-1,3-oxazino[3,2-b]isoquinoline-7,14-dione 5 was prepared by condensation of 2-amino-3-carbethoxy-4,5,6,7-tetrahydrobenzothiophene with homophthalic anhydride under microwave irradiation, followed by alkaline hydrolysis and cyclization using acetyl chloride. Compound 5 was further allowed to react with different nitrogen nucleophiles to get new tetrahydrobenzothienopyrimido isoquinolinone derivatives. The structures of the prepared compounds were elucidated by IR, 1H-NMR, 13C-NMR, and mass spectroscopy. The newly prepared compounds were tested in vitro against a panel of two human tumor cell lines, namely, hepatocellular carcinoma (liver) HepG2, and mammary gland breast MCF-7. Almost all the tested compounds showed satisfactory activity.


Other data

Title Synthesis and antitumor evaluation of novel tetrahydrobenzo[4′,5′]thieno[3′,2′:5,6]pyrimido[1,2-b]isoquinoline derivatives
Authors Mahmoud, Mahmoud R. ; Mohamed Hekal ; Ali, Yasmeen M.; Abu El-Azm, Fatma ; Ismail, Mahmoud 
Keywords Antitumor activity;homophthalic anhydride;microwave irradiation;tetrahydro benzo thien opyrimido isoquinolinone derivatives;tetrahydro benzo thiophene derivatives;RAPID COLORIMETRIC ASSAY;ANTIMICROBIAL EVALUATION;ANALGESIC ACTIVITY;AGENTS;INHIBITORS;THIENOPYRIMIDINES;PROLIFERATION;ANTICANCER;SURVIVAL;GROWTH
Issue Date 2018
Publisher TAYLOR & FRANCIS INC
Journal Synthetic Communications 
Volume 48
Issue 4
Start page 428
End page 438
ISSN 0039-7911
1532-2432
DOI 10.1080/00397911.2017.1406520
Scopus ID 2-s2.0-85040978214
Web of science ID WOS:000423777900007

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 14 in scopus


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.